- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (373)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (1)
- Reader Comments (1)
- Reference Citation Analysis (1)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4475)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 7, 2024 (publication date) through Feb 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hassan SA, Kapur N, Sheikh F, Fahad A, Jamal S. Disease clearance in ulcerative colitis: A new therapeutic target for the future. World J Gastroenterol 2024; 30(13): 1801-1809 [PMID: PMC11036494 DOI: 10.3748/wjg.v30.i13.1801] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i13/1801.htm |
| Number | Citing Articles |
| 1 |
Changfeng Qu, Chen Liang, Tianlong Liu, Yingying He, Ke Ke, Jinlai Miao. Natural zinc-rich oyster peptides ameliorate DSS-induced colitis via antioxidation, anti-inflammation, intestinal barrier repair, microbiota modulation, and SCFA accumulation. Food Bioscience 2024; 61: 104801 doi: 10.1016/j.fbio.2024.104801
|
| 2 |
Lucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, Ferdinando D’Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca. Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals 2025; 18(1): 78 doi: 10.3390/ph18010078
|
| 3 |
Shao-Jie Liang, Kun Wang, Da-Bin Mao, Li-Wei Xie, Da-Jian Zhu. Inhibition of the Wnt/β‑catenin signaling pathway and SOX9 by XAV939 did not alleviate inflammation in a dextran sulfate sodium‑induced ulcerative colitis model. Experimental and Therapeutic Medicine 2024; 29(2) doi: 10.3892/etm.2024.12774
|